2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Testicular Cancer
Testicular cancer, though relatively rare compared to other cancers, is a significant health concern affecting men, typically between the ages of 15 and 35. Recent advancements in cancer research have led to improved detection methods and treatment options for this type of cancer. One promising area of research involves the identification of specific genetic markers associated with testicular cancer, aiding in early diagnosis and personalized treatment plans. Additionally, immunotherapy has shown promise in targeting and destroying cancer cells while sparing healthy tissue, offering new hope for patients with advanced or recurring forms of the disease. Collaborative efforts between researchers, clinicians, and advocacy groups continue to drive progress in understanding and combating testicular cancer, aiming for better outcomes and quality of life for affected individuals.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China